Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

Chronic Kidney Disease IV: Nursing Management

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Value of Inpatient Clinical Pharmacists.

Journal of the American College of Clinical Pharmacy : JACCP·2026

Same author

Betrixaban for Deep Venous Thrombosis Prevention in a Patient with End-Stage Renal Disease on Intermittent Hemodialysis.

Journal of biosciences and medicines·2026

Same author

Reply to Ishii et al.: Clarifying the association between sedative selection and outcomes in acute respiratory distress syndrome: methodological considerations.

Annals of the American Thoracic Society·2026

Same author

Medication Dosing by Advanced Technologies: Promise on the Horizon but Not Without Risk.

Pharmacotherapy·2026

Same author

Creating Solutions to the Challenges in Managing Heparin Infusions: Exploring Use of Technology Including Artificial Intelligence and the Role of Anticoagulation Stewardship.

The Annals of pharmacotherapy·2025

Same author

Geographic Variations of Intensive Care Unit Admissions with Substance-Related Diagnoses in the United States.

Journal of intensive care medicine·2025

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Systemic anticoagulation considerations in chronic kidney disease.

William E Dager¹, Tyree H Kiser

¹University of California, Davis Medical Center, Sacramento, 95817-2201, USA. william.dager@ucdmc.ucdavis.edu

Advances in Chronic Kidney Disease

|August 24, 2010

Summary

Managing anticoagulation in chronic kidney disease (CKD) patients requires careful consideration due to bleeding risks and limited trial data. This review examines anticoagulants and reversal strategies for CKD patients.

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Related Experiment Videos

Last Updated: Jun 10, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Area of Science:

Nephrology
Hematology
Pharmacology

Background:

Anticoagulation is vital for preventing thromboembolic disorders in chronic kidney disease (CKD) patients.
Renal insufficiency complicates anticoagulation due to hypercoagulable states and increased bleeding risks.
Clinical trial data for anticoagulation in severe renal impairment or hemodialysis is scarce.

Purpose of the Study:

To review systemic anticoagulation strategies for patients with chronic kidney disease.
To discuss challenges and evidence gaps in managing anticoagulation for CKD patients.
To explore various anticoagulant agents and reversal methods.

Main Methods:

Literature review of anticoagulation in CKD.
Analysis of anticoagulants including warfarin, heparin, fondaparinux, and direct thrombin inhibitors.
Discussion of emerging anticoagulants and reversal strategies.

Main Results:

Anticoagulant management in CKD presents unique challenges due to altered physiology.
Limited evidence exists for optimal dosing and monitoring in severe renal impairment.
Various anticoagulant classes have specific considerations in CKD.

Conclusions:

Systemic anticoagulation in CKD requires tailored approaches due to patient-specific factors.
Further research is needed to guide anticoagulation and reversal in CKD populations.
Careful selection and monitoring of anticoagulants are crucial for CKD patients.